Skip to main content
OTCMKTS:AVTI

Avitar Stock Forecast, Price & News

$0.0008
+0.00 (+14.29 %)
(As of 05/14/2021 08:27 PM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.00
Volume3.54 million shs
Average Volume2.87 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-0.4
30 days | 90 days | 365 days | Advanced Chart
Receive AVTI News and Ratings via Email

Sign-up to receive the latest news and ratings for Avitar and its competitors with MarketBeat's FREE daily newsletter.


About Avitar

Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.

Headlines

Avitar Inc (AVTI)
Avitar Inc (AVTI)
April 26, 2021 |  nasdaq.com
Commerce Energy Group, Inc. (CMNR)
Commerce Energy Group, Inc. (CMNR)
March 28, 2020 |  nz.finance.yahoo.com
Avitar Inc
Avitar Inc
January 1, 2020 |  markets.ft.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AVTI
CUSIPN/A
Phone781-821-2440
Employees36
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.52 out of 5 stars

Medical Sector

1534th out of 2,042 stocks

Surgical Appliances & Supplies Industry

35th out of 40 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Avitar (OTCMKTS:AVTI) Frequently Asked Questions

What stocks does MarketBeat like better than Avitar?

Wall Street analysts have given Avitar a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Avitar wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Avitar's stock been impacted by COVID-19 (Coronavirus)?

Avitar's stock was trading at $0.0002 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AVTI stock has increased by 300.0% and is now trading at $0.0008.
View which stocks have been most impacted by COVID-19
.

Who are Avitar's key executives?

Avitar's management team includes the following people:
  • Mr. Cory H. Gelmon, CEO, Pres, Treasurer & Sec. (Age 61)

Who are some of Avitar's key competitors?

What other stocks do shareholders of Avitar own?

What is Avitar's stock symbol?

Avitar trades on the OTCMKTS under the ticker symbol "AVTI."

How do I buy shares of Avitar?

Shares of AVTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avitar's stock price today?

One share of AVTI stock can currently be purchased for approximately $0.00.

How many employees does Avitar have?

Avitar employs 36 workers across the globe.

What is Avitar's official website?

The official website for Avitar is www.avitarinc.com.

Where are Avitar's headquarters?

Avitar is headquartered at 65 DAN ROAD, CANTON MA, 02021.

How can I contact Avitar?

Avitar's mailing address is 65 DAN ROAD, CANTON MA, 02021. The company can be reached via phone at 781-821-2440.


This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.